Aberrant signal transduction pathways in myeloproliferative neoplasms.

Abstract excerpt

The BCR-ABL-negative myeloproliferative neoplasms (MPNs), polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF), entered the spotlight in 2005 when the unique somatic acquired JAK2 V617F mutation was described in >95% of PV and in 50% of ET and PMF patients. For the very rare PV patients who do not harbor the JAK2 V617F mutation, exon 12 JAK2 mutants were discovered also to result...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Polycythemia Vera
• Share to Primary Myelofibrosis
• Share to Receptors, Erythropoietin